[Fibrates: their prescription must be restricted].

Authors :: Béliard-Lasserre S
Source :: La Revue du praticien [Rev Prat] 2015 Dec; Vol. 65 (10), pp. 1243-4.
Publication Year :: 2015

Subjects :: Cardiovascular Diseases prevention & control
Diabetes Mellitus, Type 2 complications
Fenofibrate therapeutic use
Fibric Acids adverse effects
France
Gemfibrozil therapeutic use
Guidelines as Topic
Humans
Hypolipidemic Agents therapeutic use
Meta-Analysis as Topic
Pancreatitis prevention & control
Randomized Controlled Trials as Topic
Risk Factors
Drug Prescriptions standards
Fibric Acids therapeutic use
Hypertriglyceridemia drug therapy

Tools